As expected, low cash burn rate, hence on schedule for trial enlisting and follow up evaluations.
As stated by the company public announcements on several disclosures ptx's science is in 'pregnency mode', that is their drugs on trial are not needing, at current, further developement but rather validation alone.
Funded well to at least phase 2 in all trails, happy to hold and accumilate.
GLTAH
- Forums
- ASX - By Stock
- PTX
- Ann: December 2015 Appendix 4C - Quarterly
Ann: December 2015 Appendix 4C - Quarterly, page-4
Featured News
Add PTX (ASX) to my watchlist
|
|||||
Last
4.2¢ |
Change
0.003(6.41%) |
Mkt cap ! $31.40M |
Open | High | Low | Value | Volume |
4.1¢ | 4.2¢ | 4.1¢ | $3.391K | 82.08K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1524 | 4.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.2¢ | 215270 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1524 | 0.041 |
2 | 24977 | 0.040 |
2 | 86360 | 0.039 |
2 | 550222 | 0.038 |
9 | 729707 | 0.037 |
Price($) | Vol. | No. |
---|---|---|
0.042 | 215270 | 2 |
0.043 | 68203 | 3 |
0.044 | 286522 | 2 |
0.045 | 409634 | 4 |
0.046 | 298002 | 2 |
Last trade - 12.28pm 04/07/2024 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |